Abstract
Alcohol use disorder (AUD) is heterogenous, and criteria can be met through several expressions of harmful use (Watts et al., 2021) ranging from frequent binge drinking episodes and low-grade excessive consumption (e.g., 2 drinks every evening), to everyday use associated with neurobiological changes seen in active addiction. Precise understanding of use patterns and the cognitive and emotional experiences that drive these patterns are key in both a research context, where neurobiological, genetic, and personality factors may differ amongst use patterns (e.g., Delawalla et al., 2023) and in a clinical intervention context, where intervention for one use pattern may look very different from another (Nadkarni et al., 2022). We derived a four-factor model of compulsive alcohol use (CAU) in a representative sample of N = 2,004 Americans. The CAU model suggests the construct is comprised of Intrusive Thoughts, Emotionality, Craving, and Loss of Control. Further, we validated the emergent models against collateral measures to verify the structure and predictive value.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by R01DA042742 and Giles RobertFoundation awarded to department of psychology.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Emory University Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
